Actively Recruiting
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
Led by State University of New York at Buffalo · Updated on 2025-03-28
1000
Participants Needed
1
Research Sites
526 weeks
Total Duration
On this page
Sponsors
S
State University of New York at Buffalo
Lead Sponsor
K
Kaleida Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.
CONDITIONS
Official Title
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis
- Subjects previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) without current steatosis or fibrosis scoring
- Subjects with other known liver diseases such as hepatitis C virus (HCV)
You will not qualify if you...
- Patients younger than 18 years old
- Pregnancy
- Patients unwilling to be contacted for future research
- Patients diagnosed with ascites or on peritoneal dialysis
- Body mass index (BMI) of 40 or higher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Conventus Medical Office Building
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
A
Ajay Chaudhuri, MD
CONTACT
A
Andrew Talal, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here